| Citation: |
ZHANG Chao, HAN Dong, FAN Dikun, GAO Jianchao, YANG Kan. Prognostic value of serum adiponectin and fibroblast growth factor-23 in patients undergoing heart valve replacement[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 58-62. DOI: 10.7619/jcmp.20233242
|
To investigate the prognostic value of serum adiponectin and fibroblast growth factor-23 (FGF23) levels in patients undergoing cardiac valve replacement.
A total of 98 patients undergoing heart valve replacement were selected as the study group. The patients in the study group were divided into good prognosis group (n=67) and poor prognosis group (n=31). A total of 90 healthy subjects were selected as control group. Spearman method was used to analyze the correlation of serum adiponectin and FGF23 levels with plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and Acute Physiology and Chronic Health EvaluationⅡ (APACHE Ⅱ) scores, respectively. Multivariate Logistic regression analysis was used to analyze the prognostic factors of patients with heart valve replacement. Receiver operating characteristic (ROC) curve was drawn to analyze the predictive value of serum adiponectin and FGF23 levels in patients with heart valve replacement.
Serum FGF23, NT-proBNP level and APACHEⅡ score in the study group were significantly higher, and serum adiponectin level was significantly lower than that in the control group (P < 0.05). The levels of serum FGF23, NT-proBNP and APACHE Ⅱ score in the poor prognosis group were significantly higher, and the serum adiponectin level was significantly lower than that in the good prognosis group (P < 0.05). Serum FGF23 level was positively correlated with NT-proBNP level and APACHE Ⅱ score (P < 0.05). Serum adiponectin level was negatively correlated with NT-proBNP level and APACHE Ⅱ score (P < 0.05). The levels of serum adiponectin, FGF23, NT-proBNP and APACHE Ⅱ score were the influencing factors for the prognosis of patients with heart valve replacement (P < 0.05). The area under the curve (AUC) of serum adiponectin and FGF23 for predicting the prognosis of patients undergoing cardiac valve replacement was 0.862 and 0.807, respectively, and the AUC of the combined prediction was 0.911. The AUC of combined prediction of adiponectin and FGF23 was higher than that of individual prediction (P < 0.05).
The combination of serum adiponectin and FGF23 has a good effect in predicting the prognosis of patients with heart valve replacement. Serum adiponectin and FGF23 are expected to be effective indicators for evaluating the prognosis of patients undergoing heart valve replacement.
| [1] |
ROBICH M P, IRIBARNE A, BUTZEL D, et al. Multicenter experience with valve-in-valve transcatheter aortic valve replacement compared with primary, native valve transcatheter aortic valve replacement[J]. J Card Surg, 2022, 37(12): 4382-4388. doi: 10.1111/jocs.17084
|
| [2] |
KEMPFERT J, KOFLER M, FALK V, et al. Minimally invasive endoscopic mitral valve repair-the new gold standard for degenerative mitral valve disease[J]. Eur J Cardiothorac Surg, 2022, 61(3): 645-646. doi: 10.1093/ejcts/ezab568
|
| [3] |
SCHOEN F J, GOTLIEB A I. Heart valve health, disease, replacement, and repair: a 25-year cardiovascular pathology perspective[J]. Cardiovasc Pathol, 2016, 25(4): 341-352. doi: 10.1016/j.carpath.2016.05.002
|
| [4] |
李秋菊, 亢婵婵. 血清NT-proBNP、hs-cTnⅠ联合IL-6检测在评估心脏瓣膜置换术患者预后中的作用[J]. 四川解剖学杂志, 2022, 30(1): 31-32, 61.
|
| [5] |
SOWKA A, DOBRZYN P. Role of perivascular adipose tissue-derived adiponectin in vascular homeostasis[J]. Cells, 2021, 10(6): 1485. doi: 10.3390/cells10061485
|
| [6] |
ASIMAKOPOULOU A, WEISKIRCHEN S, WEISKIRCHEN R. Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy[J]. Front Physiol, 2016, 7: 430.
|
| [7] |
LEIFHEIT-NESTLER M, HAFFNER D. Paracrine effects of FGF23 on the heart[J]. Front Endocrinol, 2018, 9: 278. doi: 10.3389/fendo.2018.00278
|
| [8] |
LEIFHEIT-NESTLER M, GRABNER A, HERMANN L, et al. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats[J]. Nephrol Dial Transplant, 2017, 32(9): 1493-1503. doi: 10.1093/ndt/gfw454
|
| [9] |
颜红兵, 程姝娟. 对2006年美国心脏瓣膜疾病治疗指南部分内容的评价[J]. 中国实用内科杂志, 2007, 27(22): 1738-1741. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK200722004.htm
|
| [10] |
ZAKERZADEH R, HSU M C, SACKS M S. Computational methods for the aortic heart valve and its replacements[J]. Expert Rev Med Devices, 2017, 14(11): 849-866. doi: 10.1080/17434440.2017.1389274
|
| [11] |
CRAGO M, LEE A, FARAJIKHAH S, et al. The evolution of polyurethane heart valve replacements: how chemistry translates to the clinic[J]. Mater Today Commun, 2022, 33: 104916. doi: 10.1016/j.mtcomm.2022.104916
|
| [12] |
靳云洲. CYP2C9和VKORC1基因检测指导心脏瓣膜置换术后华法林用药的研究[J]. 实用临床医药杂志, 2022, 26(1): 22-25. doi: 10.7619/jcmp.20213385
|
| [13] |
陈晓英, 彭齐, 胡大清. 三种评分系统对心脏瓣膜置换术后患者预后评估的分析[J]. 心血管康复医学杂志, 2006, 15(3): 236-238. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGK200603012.htm
|
| [14] |
王朝晖. 心脏瓣膜置换术围术期患者血浆NT-proBNP水平检测及其预后评估[J]. 中国现代医生, 2019, 57(35): 48-50, 54. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201935013.htm
|
| [15] |
闫小菊, 李勇, 张羽, 等. 血清Hcy、NT-proBNP及脂联素与老年冠心病冠状动脉病变的相关性[J]. 中国老年学杂志, 2020, 40(4): 673-678. doi: 10.3969/j.issn.1005-9202.2020.04.001
|
| [16] |
CHAN Y K, SUNG H K, JAHNG J W, et al. Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells[J]. Mol Cell Endocrinol, 2016, 430: 68-76. doi: 10.1016/j.mce.2016.04.006
|
| [17] |
孙娜, 王荣, 刘伟. 冠心病患者血清脂联素、鸢尾素及肠道菌群水平与冠状动脉狭窄的关系分析[J]. 中国分子心脏病学杂志, 2023, 23(3): 5393-5398. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGFB202303007.htm
|
| [18] |
王新梓, 邱溢博, 邓雨, 等. 维持性血液透析患者血管钙化治疗的研究进展[J]. 实用临床医药杂志, 2022, 26(22): 144-148. doi: 10.7619/jcmp.20221784
|
| [19] |
ISAKOVA T, CAI X, LEE J, et al. Longitudinal FGF23 trajectories and mortality in patients with CKD[J]. J Am Soc Nephrol, 2018, 29(2): 579-590. doi: 10.1681/ASN.2017070772
|
| [20] |
王波, 符洪犊, 蒙漫史, 等. 风湿性心脏病术后医院感染患者血清FGF23/Klotho及其与炎症状态和细胞免疫的关系[J]. 中华医院感染学杂志, 2021, 31(19): 3008-3012. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202119027.htm
|
| [21] |
郭小峰, 陈兴澎, 李斌. 基于血清学及心功能指标建立心脏瓣膜置换术患者预后预测模型的研究[J]. 临床心血管病杂志, 2019, 35(5): 468-472. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201905018.htm
|
| [22] |
杨艳丽, 马骏. 心脏多瓣膜置换术后患者急性肾损伤发生情况及预后危险因素分析[J]. 中国医药, 2018, 13(11): 1631-1633. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG201811009.htm
|
| [23] |
姚灿, 王荣珍, 刘天喜. 血清klotho蛋白、FGF23与腹膜透析患者营养状态相关性分析[J]. 临床荟萃, 2020, 35(10): 922-926. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFC202010011.htm
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: